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Abstract
A closed-loop lumped parameter model of blood circulation is considered for single-ventricle shunt physiology.
Its parameters are estimated by an inverse problem based on patient-specific haemodynamics measurements.
As opposed to a black-box approach, maximizing the number of parameters that are related to physically
measurable quantities motivates the present model. Heart chambers are described by a single-fibre mechanics
model, and valve function is modelled with smooth opening and closure. A model for valve prolapse leading
to valve regurgitation is proposed. The method of data assimilation, in particular the unscented Kalman
filter, is used to estimate the model parameters from time-varying clinical measurements. This method
takes into account both the uncertainty in prior knowledge related to the parameters and the uncertainty
associated with the clinical measurements. Two patient-specific cases – one without regurgitation and one
with atrioventricular valve regurgitation – are presented. Pulmonary and systemic circulation parameters
are successfully estimated, without assumptions on their relationships. Parameters governing the behaviour
of heart chambers and valves are either fixed based on biomechanics, or estimated. Results of the inverse
problem are validated qualitatively through clinical measurements or clinical estimates that were not included
in the parameter estimation procedure. The model and the estimation method are shown to successfully
capture patient-specific clinical observations, even with regurgitation, such as double peaked nature of
valvular flows and anomalies in electrocardiogram readings. Lastly, biomechanical implications of the results
are discussed.
Keywords: single-ventricle physiology, valve regurgitation, data assimilation, unscented Kalman filter,
patient-specific modelling, single-fibre heart model
1. Introduction
Lumped parameter models (LPM) are widely employed for assessment of haemodynamics (Shi et al.,
2011). They can be either coupled with 3D Navier-Stokes models, for e.g. to assist surgical planning (Vignon-
Clementel et al., 2010; Baretta et al., 2011; Arbia et al., 2015; Corsini et al., 2014), employed for parameter
estimation later used in 3D (Pant et al., 2014), or run independently, for e.g. to assess ranges of variation and
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the effect of functional parameters that are not easily measurable (Hann et al., 2011; Sughimoto et al., 2013).
For a patient-specific analysis, however, the LPMs need customisation for each patient individually. While
it is natural that the parameters of the LPMs be estimated via some patient-specific clinical measurements
such that the discrepancy between model output and the measurements is minimised, the inverse problem is
challenging, particularly when the number of parameters to be estimated is high. This phenomenon, often
referred to as the curse of dimensionality (Bellman et al., 1961), is associated with the exponential increase
in the search volume (the volume in the parametric space to be searched for minimising the discrepancy
function) with the number of dimensions/parameters. The problem is further exacerbated by uncertainty
in the clinical measurements. In principle, a manual tuning of the parameters could be performed, but it
is a long process requiring much biomechanical and physiological expertise (see for example, Baretta et al.
(2011)). Automatic approaches, on the other hand, are mostly confined to either models with a low number
of estimated parameters (for example 6 in Hann et al. (2010) and 2+5+5+2+2 Revie et al. (2013) where
five sub-problems are created for the full circulatory model) or open-loop circulatory models with simplified
boundary conditions (Arbia et al., 2015; Spilker and Taylor, 2010). Furthermore, such methods typically
make inherent hypotheses about the ratios of different parameters (Spilker and Taylor, 2010) or consider only
the major model parameters (Sughimoto et al., 2013) to reduce the total number of free parameters. Most
commonly a variational approach is used to minimise a loss function associated with the discrepancy between
the model output and clinical measurements (see for example Hann et al. (2004); Segers et al. (2008); Spilker
and Taylor (2010); Ismail et al. (2012); Sughimoto et al. (2013)). Other iterative approaches include fixed-
point/control-system based methods (Hann et al., 2010, 2011; Troianowski et al., 2011; Revie et al., 2013;
Xiao et al., 2013; Arbia et al., 2015). All these methods usually employ targets of the mean/extrema values
or scalar shape descriptors of the clinical measurements and are successful only when a few parameters
(in each individual sub-problem if the inverse problem is subdivided) are to be estimated. An alternate
approach for parameter estimation that has gained a lot of attention in recent years is the approach of data
assimilation. Such approaches are typically based on sequential filtering and take advantage of time-varying
measurement curves. These methods have been applied in hemodynamics to estimate tissue/wall material
properties or Windkessel parameters (Bertoglio et al., 2012; Moireau et al., 2012; Pant et al., 2014). The
first contribution of this manuscript is to present such an approach for parameter estimation in closed-loop
models of circulation with many (33) parameters of the heart and circulation.
This study considers single ventricle physiology of both hypoplastic left, and hypoplastic right ventricular
aetiology. Specifically, at the time of clinical assessment for planning second stage surgery, whereby clinical,
imaging, and pressure data are available for clinical decision-making. Moving from a post stage-I circulation
to a stage-II circulation represents a potentially great change in ventricular preload and afterload as the
systemic and pulmonary circulations are reconnected. This physiology is described in detail in Corsini et al.
(2014). Assessment of patients at this time point is challenging due to both the complex physiology, and
the inherent difficulties in acquiring clinical measurements in babies with potentially unstable physiologies.
Contrary to the commonly employed time-varying elastance based models for heart function (Mynard et al.,
2012; Sughimoto et al., 2013; Shimizu et al., 2010), cardiac chamber (ventricle or atrium) pressure and volume
are related to myofibre stress and strain in this study by a one-fibre model of cardiac mechanics (Arts et al.,
1991). Note that another lumped model with active and passive components (parameterised from 1D muscle
experiments) was derived for the left ventricle (Caruel et al., 2014). The main motivation here is that cardiac
biomechanics is described more accurately, for both the ventricle and the atrium, while limiting the number
of unknown parameters. Indeed, myofibre passive and active behaviours have been experimentally measured
and reported in the literature while other patient-specific parameters (e.g. chamber wall volume) can be
individually measured. Consequently, a number of parameters can either be eliminated from the inverse
problem, or their estimates can be validated through the measured values. The application of such a model
to assess patient-specific cardiac function in this challenging single-ventricle pathophysiology is the second
contribution of this study.
The final contribution of this study concerns modelling of heart valves. In single ventricle circulations,
atrioventricular valve regurgitation is associated with poor longterm outcome (Honjo et al., 2011a). In these
patients the mechanism of regurgitation is likely to be multifactorial. Among lumped parameter models
of valves, a pure diode-like behaviour has been adopted where the valve is either entirely open or entirely
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closed at any time (Shimizu et al., 2010; Baretta et al., 2011; Corsini et al., 2011) or quite complex models,
requiring a large number of parameters, have been used to simulate smooth opening/closure (Korakianitis
and Shi, 2006; Paeme et al., 2011). An intermediate simpler approach has been developed by Mynard
et al. (2012) describing valve dynamics effectively through few parameters. Nevertheless, in all cases valve
regurgitation is simply modelled as due to an incomplete and stable leaflet closure, without accounting for
possible valve prolapse. Here, an improvement of the model by Mynard et al. (2012), where valve dynamics
is modified to include valve prolapse, is presented. This new model is utilised in single-ventricle physiology
and patient-specific valve parameters are estimated.
The above three contributions are tested on two patient-specific cases: one without regurgitation and one
with atrioventricular valve (AVV) regurgitation due to prolapse. A large number of parameters (at least 33
per patient) are estimated for each patient from different kind of clinical measurements – magnetic resonance
imaging (MRI), Doppler velocimetry, and pressure catheter measurements – with different levels of associated
uncertainty. The inverse problem is solved through the data assimilation method of the unscented Kalman
filter, and the results are validated qualitatively through measurements that are not used for parameter
estimation: Doppler velocimetry measurements of valvular flows, MRI valvular area and ventricular wall
and cavity volume measurements, four-chamber echocardiography measurements to derive atrial volumes,
and electrocardiography (ECG) measurements for timing of cardiac events.
2. Model and Methods
2.1. Closed-loop model for single-ventricle physiology
The closed-loop model for single-ventricle physiology is depicted in Figure 1. The four districts of
circulation – the heart, upper body, lower body, and the lungs – are lumped individually. Owing to the
atrial septal defect the two chambers are considered as a single atrium (SA). The SA is connected via the AVV
to the single ventricle (SV) which in turn feeds into the systemic circulation via the aortic valve (AOV).
The connection between the systemic and pulmonary circulations is made via a systemic-to-pulmonary
artery shunt (SH) that connects the aorta to the pulmonary artery. The systemic and pulmonary districts
are described in a similar manner (except for inclusion of shunt in the Lung district) through a series of
elements representing linear viscous losses (R), quadratic viscous losses (K), blood inertia (L), and vessel
wall compliances (C). In Figure 1, similar to Baretta et al. (2011), the large arteries (with subscript 1),
small vessels (with subscript 2), and veins (with subscript 3) are distinctly represented. An algebraic and
ODE system describing the model haemodynamics can be written. The pressure-flow relationships followed
by R, K, L and C components are shown in Table 1, while sections 2.2 and 2.3 describe the heart and valve
models. Lastly, mass balance at every node of Figure 1 completes the ODE system.
2.2. Single fibre model for a heart chamber
A heart chamber (SA or SV) is described by a single fibre wrapped around the cavity (Arts et al., 1991,
2003; Bovendeerd et al., 2006). This model is particularly suitable for lumped modelling as it was shown
that under rotational symmetry the shape of the chamber and other geometric parameters had little effect
on the relationship between the cavity pressure and fibre stress (Arts et al., 1991). This relationship is
dominated by the ratio of the cavity volume V to wall volume Vw (volume of the cavity wall), and is given
by
σf
P
=
(
1 +
3V
Vw
)
(1)
where P represents the pressure of the chamber and σf is the stress in the fibre. The fibre stress is composed
of two components: an active component σa and a passive component σp
σf = σa + σp (2)
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Figure 1: Schematic of a closed-loop model for single-ventricle circulation. The heart components are derived in sections 2.2
and 2.3. For description of other components see table 1. The measurements for parameter estimation are shown in red, while
the measurements for validation are shown in blue.
If V0 and l0 represent the state of the cavity and sarcomere length, respectively, at zero transmural pressure,
then at a general state of cavity volume V , the sarcomere length, l, can be written as
l
l0
= λ =
(
1 + (3V /Vw)
1 + (3V0/Vw)
)1/3
(3)
where λ is the fibre stretch ratio. The sarcomere shortening velocity, vs, is given by
vs = −dl
dt
= − l
Vw
(
1 +
3V
Vw
)−1
dV
dt
(4)
The active component of the stress is described as
σa = Ta0 f(l) g(ta) h(vs) (5)
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Figure 2: Sarcomere properties and chamber activation functions
f(l) =

0, if l < la0
(l − la0)/(lam − la0), if la0 < l ≤ lam
1.0, if lam < l ≤ lae
(laf − l)/(laf − lae), if l > lae
(6)
g(ta) =

[
1
2
(
1− cos
(
2pi tatmax
))]Ea
, if ta < tmax
0, otherwise
(7)
h(vs) =
1− (vs/v0)
1 + cv (vs/v0)
(8)
where ta is the time since activation of the cavity, tmax is the total time of activation in a cardiac cycle, v0
is the initial sarcomere shortening velocity, Ta0 is the maximum active sarcomere stress, and cv is a shape
parameter. The functions f(l) and g(ta) are shown in Figure 2. Note that the function g(ta) is parameterised
to allow for overlaps between the atrial and ventricular contractions. The passive stress is given by
σp =
{
0, if λ < 1
Tp0 (exp {cp(λ− 1)} − 1) , if λ ≥ 1
(9)
where Tp0 and cp are sarcomere material constants. The relationship between P , V , and dV/dt of a heart-
chamber is thus given by equations (1) – (9).
2.3. A model for valve function
Valve regurgitation may be associated to either an incomplete closure of the valve leaflets or due to valve
prolapse (Honjo et al., 2011a,b). For valve function, the model proposed in Mynard et al. (2012) is modified
to include the latter. For a fluid with density ρ, the pressure drop across a valve is described by the Bernoulli
relation
∆p = Bq|q|+ Ldq
dt
(10)
B =
ρ
2A2eff
and L =
ρ leff
Aeff
(11)
where Aeff and leff are the effective area and effective length of the valve, respectively. Note that, the viscous
losses are small and thus neglected (Mynard et al., 2012; Sun et al., 1995). The valve state can be described
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Table 1: Pressure and flow-rate relationship for various components: p represents pressure and q represents flow-rate
Component pressure-flow relationship Component pressure-flow relationship
p1
R q
p2 p1 − p2 = R q p1
q
p2
K
p1 − p2 = K q|q|
p1
L q
p2
p1 − p2 = L q˙
q1 p
C
q2
q1 − q2 = C p˙
by a single variable, ξ(t), which in turn depends on the pressure difference across the valve, ∆p = pup−pdown
(e.g. pup = pSA and pdown = pSV for AVV). The dependence of the valve effective area on ξ(t) is different
according to valve condition, namely:
Aeff(t) =

Amaxeff ξ(t) if valve is not regurgitant
Aeff(t) =
(
Amaxeff −Amineff
)
ξ(t) +Amineff if valve is regurgitant due to incomplete leaflet closureA
max
eff ξ(t) if ξ ≥ 0
−Ar,maxeff ξ(t) if ξ < 0
if valve is regurgitant due to prolapse
(12)
Generally, ξ(t) varies between -1 and +1. In the first two cases ξ(t) is always positive, whereas in the
prolapse case it can become negative. Note that the maximum number of parameters to identify is two.
Four dynamic valve states are taken into account, namely i) opening, ii) closing, iii) prolapse increasing,
and iv) prolapse decreasing:
ξ˙ = (1− ξ) Kvo ∆p if ∆p ≥ 0
ξ˙ = ξ Kvc ∆p if ∆prg ≤ ∆p < 0 and ξ ≥ 0
ξ˙ = (1 + ξ) Krvo (∆p−∆prg) if ∆p ≤ ∆prg
ξ˙ = −ξ Krvc (∆p−∆prg) if ∆p > ∆prg and ξ < 0,
(13)
where Kvo, Kvc, K
r
vo, and K
r
vc are the proportionality rates.
If the valve does not prolapse, only the first two equations hold. When ξ(t) is zero, the valve is closed.
It is assumed that valve starts to open when ∆p > 0 and starts to close when ∆p < 0. Prolapse starts when
∆p < ∆prg, assuming that valvular structures (e.g. chordae tendineae) cannot maintain a competent valve
for excessive negative ∆p.
2.4. Data assimilation for parameter estimation
Data assimilation refers to the process of merging numerical model predictions with available measure-
ments to provide an improved estimate of the dynamical system (Bertagna et al., 2014). It is well suited for a
patient-specific analysis, since the mathematical description is combined with clinical measurements. For the
choice of unscented Kalman filter (UKF) for data assimilation, its appropriateness for parameter estimation
in non-linear systems, and application to haemodynamics, Pant et al. (2014) is referred. The method is now
briefly described. Consider a dynamical system described by state variables x ∈ Rd, x = [x1, x2, . . . , xd]T
and parameterised by θ ∈ Rp, θ = [θ1, θ2, . . . , θp]T , with following dynamics
xn+1 = F (xn,θ), (14)
where xn and xn+1 refer to the state at times tn and tn+1. Equation (14) can, for example, be considered
as a discretised form of the ODE system x˙ = F(x,θ). Consider that at time tn, measurements of vector
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y ∈ Rm, y = [y1, y2, . . . , ym]T are available and related to the state through the observation operator H and
measurement noise  as follows
yn = H(xn) + n. (15)
In the above, the noise at all measurement times is assumed to be independent and distributed according to
a multivariate Gaussian distribution with zero mean and covariance Σn. The goal of all filtering methods
is to provide estimates of xn recursively at each measurement time tn through the measurements yn. This
is achieved through two steps of propagation and correction. Assume that an estimate of state is available
at time tn with mean xˆn and covariance Pn. The forward propagation step involves propagation of the
mean and covariance from tn to tn+1 through the forward model of equation (14). In the correction step,
these means and covariances are corrected through the measurement of yn+1 to yield an estimate of mean
xˆn+1 and covariance Pn+1 at tn+1. Thus, starting from an initial estimate of the state with mean x0 and
covariance P0, an estimate of the state is available at all times through the filter. Parameter estimation is
performed by considering an augmented state containing the parameters zn = [xn,θn]
T and adding trivial
dynamics θ˙ = 0, i.e. θn+1 = θn, for the parameters in equation (14). The filter is run on the augmented
state z, and the θ component of filtered z at the last measurement time is taken as the final parameter
vector estimate (Pant et al., 2014). The estimate of the parameters depends on three factors: a) the manner
in which the parameters affect the measured quantities, i.e. the operators F and H in equations (14) and
(15); b) the uncertainty associated with prior knowledge about the parameters and the state, i.e. x0 and
P0; and c) the uncertainty associated with the clinical measurements, i.e. yn and Σn. As a general rule for
parameter estimation, the prior variances in P0 are set to relatively higher values compared to the variances
in Σn to imply that initial guess of z0 = [x0,θ0]
T has less confidence when compared to the measurements
(Pant et al., 2014).
2.5. Patient-specific cases
Two patient-specific cases (pre stage-II single ventricle shunt physiology) are considered. Institutional
Review Board approval and consent from guardians were obtained. Both patients underwent MRI, cardiac
catheterization, and trans-thoracic echocardiography for pre-stage-II surgical planning at the routine point
of pre-operative assessment (see Appendix).
Patient-A, 3 months old with a body surface area (BSA) of 0.26 m2, has a hypoplastic right ventricle due
to tricuspid and pulmonary atresia. The representative heart rate is 116 beats per minute (bpm) and there is
no valve regurgitation as assessed by MRI and echocardiography. Stage 1 surgery was a 4mm right modified
Blalock-Taussig shunt. Patient-B, 5 months old with a BSA of 0.34 m2, has a hypoplastic left ventricle due
to aortic atresia and mitral hypoplasia. Stage 1 surgery was a 3.5mm right modified Blalock-Taussig shunt.
The representative heart rate is 140 bpm and an AVV regurgitation fraction of 25 % is measured by MRI.
For both the patients, the ODE system for the forward model and the UKF are implemented in-house
in the Python programming language (with Cython compiler) using the modules NumPy, SciPy, and mul-
tiprocessing (for a parallel propagation of Sigma-points in the UKF). All simulations are run on an HPC
node (RAM 48 GB) with 2 Intel Xeon X5650 processors, each with 6 cores and 12 threads. In this setting,
with 20 parallel processes the UKF takes around 140 seconds to assimilate observations at 200 discrete time
instants in one cardiac cycle.
2.6. Parameters to be estimated and available measurements
An advantage of the mechanics-based heart model is that the sarcomere material parameters need not be
estimated. Consequently, these are kept fixed to literature values (Beyar and Sideman (1984); Bovendeerd
et al. (2006)), see Table 2. The activation functions are governed by three parameters (see Figure 2b): taSV
and taSA , the ventricle and atrium activation durations, respectively, and t1, a small overlap between them.
For both patients, Amineff is set to zero. Thus, for patient-A with no AVV regurgitation only A
max
eff , and for
patient-B Amaxeff and A
r,max
eff , need to be estimated. The opening and closing rate constants are fixed to those
reported for different valves in Mynard et al. (2012). In absence of empirical measures for regurgitant valves,
these rates are considered normal in the regurgitation model. Lastly, the shunt parameters RSH and KSH
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Table 2: Reference values for sarcomere material behaviour
Parameter Value Parameter Value Parameter Value
l0 1.9 µm lae 2.4 µm Ta0 55 kPa
la0 1.65 µm v0 10 µm/s Tp0 0.9 kPa
lam 2.2 µm cp 12 cv 0
are fixed according to shunt diameter (Migliavacca et al., 2000). The identified parameters are summarised
in Table 3.
For parameter estimation the following measurements (see Figure 1 labels in red) are used for patient-A:
pressure catheter measurements of pSA and pAO; MRI flow-rate measurements for qAO, qLB, qPV, qIVC, and
qSVC; measurement curve for qLU constructed through Doppler velocimetry measurements of shunt flow and
the findings of Migliavacca et al. (2000); and qUB obtained via mass balance. For patient-B, an identical set
is used, except that qLB is based on Doppler velocimetry in absence of MRI measurement.
For validation, the following measurements are used (see Figure 1 labels in blue): pressure catheter pSV,
Doppler velocimetry measurements qAVV and qAOV, the pulmonary venous wedge pressure, MRI SV wall
volumes, atria areas in the four-chamber echocardiography view, and ECG measurements.
3. Results and discussion
3.1. Patient-A
The parameters evolution by the UKF is shown in Figure 3. From an initial guess, the UKF contin-
uously corrects the parameters until convergence (stabilisation) such that the time-curves of the provided
measurements are closely reproduced. Their final estimates are shown in Table 3. Model predictions and the
clinical measurements are compared in Figure 4. Pressure in the single-ventricle is presented for qualitative
validation as it is not provided to the UKF for parameter estimation. The mean flow-rates in the model,
though not explicit targets in the UKF, have 5% maximum errors compared to the clinical measurements.
Pressure drop in any systemic district occurs primarily in small-vessels/capillaries. This is reflected cor-
rectly in the parameter estimates where in each district the resistance R2 (reflecting pressure drop in the
small vessels) is higher than both R1 and R3 (reflecting pressure drop in the arteries and veins). Compar-
ing pulmonary venous wedge pressure measurements (Figure 5a) to p1LU time-tracings in Figure 4 shows
a good agreement in its range of variation. The model is further validated by valvular flows. Comparing
qAVV in model predictions of Figure 4 to its velocimetry measurements in Figure 5b it is observed that the
double-peak structure is reproduced in the model. Similarly, for qAOV, Figure 5c shows a small but clearly
identifiable back-flow during valve-closure (end of ventricular systole), which is reproduced in the model.
These observations and validation for valvular flow-rates are particularly encouraging as they are a result
of the smooth opening/closure model. The commonly employed ideal-diode model cannot reproduce such
physiological flow-rates.
As mentioned above, the heart model was chosen for its parameters physical interpretation and possible
direct measurement. For example the measured SV wall volume is 34.2 ml. Its estimation is 33.9 ml, and
provides further confidence in both the model and the parameter estimation method. Similarly, at a higher
heart-rate of 136 bpm, MRI ventricular volumes were measured to be 29 ml and 10 ml at end diastole and
end systole, respectively. In the model, at a heart-rate of 116 bpm, these vary between 24.5 ml and 10.7
ml, which is in good agreement with the measurements given that the heart rate, and hence stroke volume,
is higher. The atrium volume measurement is more difficult. A rough clinical estimate can, however, be
obtained via area measurements through echocardiography four-chamber view. The right and left atria
areas are measured to vary from 3.0–4.5 cm2 and 2.0–2.5 cm2, respectively. Under the simplification of
spherical geometry, the combined volume is estimated to vary from 6.03 ml to 10.15 ml. In the model it
varies between 8.1 ml and 15.5 ml, which agrees reasonably with the rough clinical estimates.
The MRI reconstructed AVV and AOV annulus areas are 2.8 cm2 and 2.0 cm2. These measurements
are also consistent with MRI measurements of the maximum orifice area (leaflet opening area). In the
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model, the maximum effective area reflects directly neither the annulus area nor the leaflet area, but the
maximum area of the jet-flow across the valve. One way to convert the area at leaflet level to the jet area
is to consider hydraulic constants, which can result in the jet area being smaller than the leaflet area by
factors between 0.4 and 0.7 (Segal et al., 1987). A comparison of the model predictions to the maximum
leaflet area measurements yields a factor of 0.4 and 0.785 for the AVV and AOV, respectively.
3.2. Patient-B
Patient-B is a particularly challenging paediatric case to model, not only due to the presence of 25% AVV
regurgitation, but also due to higher aortic pressures (∼ 120 mmHg) and highly oscillating venous flows. For
example, while the measured IVC mean-flow is 3 ml/s, it oscillates between +/-100 ml/s during the cardiac
cycle. Furthermore, the available pressure measurements and MRI flow-rates were acquired at different
heart rates of 106 bpm and 140 bpm, respectively. Lastly, the flow-rates qLB and qUB are constructed via
Doppler velocimetry and consequently their time-variation needs to be accounted with care. In the UKF
method this is achieved by providing a relatively higher measurement error variance for these measurements
in comparison to those for the MRI flow-rates.
For patient-B, the regurgitant area Ar,maxeffAVV needs to be additionally estimated. ∆prg is fixed to -50
mmHg based on numerical experiments. A first parameter estimation, while successfully reproducing the
measurements closely, yielded an abnormally high ventricle wall volume (130 ml). On further examination,
for the measured wall volume of 40 ml and the measured end systolic volume of 13 ml, the passive stress
behaviour of equation (9) with reference values of Tp0 = 0.9 and cp = 12, yields a ventricular end diastolic
pressure (EDP) of ∼ 18 mmHg. The EDP in the patient was measured to vary from 4–8 mmHg (it usually
varies from 0–7 mmHg in normal adults (Berne and Levy, 1967)) implying that the passive stress in the
ventricle is overestimated. This could be due to ventricular remodelling or due to the difference between
passive behaviour of the right and left ventricles (Moskowitz, 1982). Note that the reference values for
the passive behaviour are based on myocardium strips obtained from left ventricles and patient-B has a
functioning right ventricle.
Having established that the passive behaviour needs to be estimated for patient-B, another UKF estima-
tion is performed where the ventricle wall volume is fixed to 40 ml and the parameter Tp0 governing passive
behaviour, see equation (9), is estimated. The parameters evolution in the UKF in Figure 6 show good
convergence to their final estimates (Table 3). The model outputs compare well with the measurements in
Figure 7. The AVV behaviour is modelled as expected for valve prolapse (ξAVV goes to -1 during ventricular
systole). Consequently, qAVV is negative in this time-interval, with mean regurgitation flow of 10.3 ml/s
(measured: 10.5 ml/s). The cardiac output is 41.0 ml/s compared to the measured value of 41.5 ml/s
(calculated via end diastolic and end systolic volumes both in the model and the measurements). This leads
to a regurgitation fraction of 22.7 % compared to the measurement of 25.3 %. The model thus reasonably
captures the global features of AVV regurgitation.
In Figure 7, all time-varying measurements provided to the UKF are reasonably well reproduced by the
model given the aforementioned high uncertainties in some flow-rate measurements and their inconsistency
with pressure measurements. In comparison to patient-A, the double-peaked nature of atrial pressure is less
pronounced in patient-B (see Figures 4 and 7) in both the measurements and the model outputs. This is
likely due to regurgitant flow from the ventricle to the atrium which raises its volume, and consequently
its pressure, during this period for patient-B. As for patient-A, the range of variation of p1LU , reflective of
pulmonary artery pressure in the model, is consistent with the range of variation in the measurements of
pulmonary venous wedge pressure (Figures 7 and 8a).
The activation durations taSA and taSV relative to the cardiac time-period (0.51 s for patient-A and 0.43
s for patient-B) are higher in patient-B than patient-A, see Table 3. In fact these estimates suggest that
the atrium activation starts before the end of ventricular activation, see Figure 2b. While seemingly odd,
this behaviour is observed clinically: Figure 8b shows an abnormal ECG reading for this patient where the
T-wave is merged with the P-wave of the next cardiac cycle. This agreement is very encouraging for both
the model and parameter estimation method.
Volume variation of the atrium is higher in patient-B. This is reasonable, as clinically an enlarged right
atrium is observed. In the four-chamber view, the left and right atrium areas vary between 1.86–2.73 cm2
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Table 3: Parameters estimated by the UKF. The numbers in parenthesis are fixed parameters
Parameter Estimate (patient-A) Estimate (patient-B) unit
V0SA 6.37 11.41 ml
VwSA 1.30 2.55 ml
V0SV 12.4 10.84 ml
VwSV 33.9 (40) ml
AmaxeffAVV 1.10 2.64 cm
2
AmaxeffAOV 1.57 0.92 cm
2
Ar,maxeffAVV - 0.036 cm
2
CAO 4.6E-02 2.2E-02 ml/mmHg
R1LB 1.08 3.42 mmHg.s/ml
R2LB 6.62 15.24 mmHg.s/ml
R3LB 0.18 0.044 mmHg.s/ml
KLB 5.0E-03 0.03 mmHg.s
2/ml2
L1LB 0.027 5.5E-03 mmHg.s
2/ml
C1LB 0.14 0.045 ml/mmHg
C2LB 3.09 3.35 ml/mmHg
R1UB 0.60 0.40 mmHg.s/ml
R2UB 3.26 6.50 mmHg.s/ml
R3UB 0.76 0.16 mmHg.s/ml
KUB 3.3E-03 1.97E-02 mmHg.s
2/ml2
L1UB 4.0E-04 1.06E-02 mmHg.s
2/ml
C1UB 0.11 0.10 ml/mmHg
C2UB 0.12 0.30 ml/mmHg
R1LU 7.9E-03 0.11 mmHg.s/ml
R2LU 0.54 0.21 mmHg.s/ml
R3LU 0.23 0.08 mmHg.s/ml
L1LU 0.40 0.045 mmHg.s
2/ml
C1LU 0.11 0.11 ml/mmHg
C2LU 0.06 0.64 ml/mmHg
CSH 1.0E-04 0.02 ml/mmHg
EaSA 1.42 1.72 -
EaSV 0.50 0.48 -
taSA 0.15 0.26 s
taSV 0.31 0.32 s
t1 0.05 0.04 s
Tp0 (0.9) 0.15 kPa
10
5.0
5.5
6.0
6.5
7.0
V0SA
0
5
10
VwSA
5
10
15
20
V0SV
10
20
30
40
VwSV
0
1
2
3
AmaxeffAVV
1.0
1.5
2.0
2.5
AmaxeffAOV
0.02
0.04
0.06
0.08
0.10
CAO
0
1
2
3
4
R1LB
0
2
4
6
8
R2LB
0.0
0.1
0.2
R3LB
0.00
0.01
0.02
0.03
KLB
0.00
0.01
0.02
0.03
0.04
L1LB
0.0
0.2
0.4
0.6
C1LB
0
2
4
6
C2LB
0.0
0.5
1.0
1.5
R1UB
0
5
10
15
R2UB
0.5
1.0
1.5
2.0
R3UB
0.000
0.005
0.010 KUB
0.000
0.002
0.004 L1UB
0.2
0.4
C1UB
0.0
0.2
0.4
0.6
0.8
C2UB
0.00
0.05
0.10
0.15
R1LU
0
1
2
3
R2LU
0.0
0.1
0.2
0.3
R3LU
0.1
0.2
0.3
0.4
L1LU
0.0
0.2
0.4
0.6
C1LU
0.04
0.06
0.08
0.10
0.12
C2LU
0.000
0.001
0.002
0.003
0.004
CSH
0 5 10 15 20 25 30 35
0.5
1.0
1.5
2.0
EaSA
0 5 10 15 20 25 30 35
0.4
0.6
0.8
EaSV
0 5 10 15 20 25 30 35
0.0
0.2
0.4
0.6 taSA
taSV
0 5 10 15 20 25 30 35
0.02
0.03
0.04
0.05
t1
Figure 3: Parameter evolution with UKF for patient-A: time in x-axis (50 cardiac cycles); volumes are in ml; areas (A) are
in cm2; linear resistances (R) are in mmHg.s/ml; quadratic resistances (K) are in mmHg.s2/ml2; compliances (C) are in
ml/mmHg; inductances (L) are in mmHg.s2/ml; and time is in s.
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Figure 5: Validation measurements for patient-A
and 6.52–8.24 cm2, respectively, yielding a combined volume variation of 14.4–21.2 ml. This is consistent
with the model output (9.0–23.6 ml). For the ventricle, the measured end systole and end diastole volumes,13
and 30 ml, respectively are in good agreement with the model (12.7–30.3 ml).
Considering hydraulic coefficients (see previous section) yields a factor of 0.98 and 0.45 between the jet-
area and the maximum leaflet area of the AVV for normal and regurgitant flow, respectively. This factor for
the AOV is 0.38. All mean flow-rate measurements and model outputs differ by less than 5%, except for qIVC
where the error is 15% (model: 3.45 ml/s; measured: 3.0 ml/s). Recall that this flow oscilates between +/-
100 ml/s. Nevertheless, the time variation is actually well reproduced by the model (see Figure 7). Including
exact mean-flow rate measurements in the UKF can easily be implemented through constraints (Pant et al.,
2014), but is avoided here owing to measurements uncertainties, particularly for highly oscillatory flows.
Overall, the UKF method is able to successfully estimate 33 and 34 parameters for patients A and B,
respectively. In both cases, the results are in good agreement with clinical observations. It should be noted
that the UKF is sensitive to the initial guesses and associated variances for the state and the parameters
(c.f. Pant et al. (2014)). In this light, a reasonable choice of the initial conditions based on model physics
and prior knowledge is important.
4. Conclusion
A lumped parameter network for single-ventricle shunt physiology, with physiologically meaningful heart-
model parameters, is presented. In addition, a new model for regurgitation due to valve prolapse with smooth
opening and closure of the valves is proposed. It is tested for the tricuspid valve but can be used for other
heart valves both in the paediatric and adult populations. Data-assimilation method for estimating a large
number of parameters from time-varying clinical measurements is successfully tested. Even though a large
number of parameters is estimated, no assumptions regarding the usually employed relationships between
the parameters is enforced. This method is applied to two patient-specific cases to estimate the model
parameters such that the clinical measurements are well-reproduced in the model. For the patient with
atrioventricular valve regurgitation, the measured regurgitation fraction of 25% is well reproduced by the
model. The results are further validated by easily measurable and mostly non-invasive clinical measurements
such as Doppler velocimetry, ECG, and echocardiography. The model and the parameter estimation method
are shown to capture clinical observations such as double-peaks in valvular flows and anomalies in atrial and
ventricular contraction durations. The presented models and method can be used in surgical planning, for
example in a 3D-LPN coupled haemodynamic studies, or for assessment of functional parameters that are
not easily measurable. Furthermore, in a pure LPN setting the effects of increasing heart rate, worsening of
regurgitation, etc., can be examined and compared between patients. Lastly, while the patient-specific cases
of single-ventricle physiology are presented in this study, the method of parameter estimation is applicable
to other physiologies provided a model and enough measured targets are available.
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Figure 8: Validation measurements for patient-B
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Appendix
Details of the haemodynamics measurements. MRIs were acquired on commercially available 1.5T scan-
ners (Philips Intera Achieva, Best, Netherlands; and Siemens Avanto, Siemens Medical Solutions, Erlangen,
Germany). A routine pre-stage-II clinical protocol was followed to acquire functional, flow, and three-
dimensional information. Free-breathing, electrocardiogram (ECG)-gated velocity-encoded phase contrast
imaging sequences were used to acquire flow measurements in multiple locations. Flow measurements
were calculated using an in-house plug-in for OsiriX open-source software (OsiriX Foundation, Geneva,
Switzerland). A contrast-enhanced three-dimensional angiogram was acquired following administration of
0.2mmol/kg gadoteridol. Cardiac catheterization followed a routine clinical protocol and occurred under
general anaesthesia in a bi-plane fluoroscopy suite (Siemens Medical Solutions USA, Inc. Pennsylvania). A
fluid-filled catheter system was used to acquire pressure traces and haemodynamic measurements in various
systemic and pulmonary arterial and venous locations. Routine echocardiography assessed ventricular and
AV valve function; and acquired pulse wave Doppler velocimetry in multiple locations.
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